Back to News
May 20, 2026 4:00 PM

Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery

Bristol-Myers Squibb Co. (NYSE:BMY) shares are trading higher on Wednesday as the company is announcing a strategic agreement with Anthropic to deploy AI across its operations.

The collaboration aims to enhance the discovery and development of new medicines, leveraging Anthropic’s advanced AI capabilities to connect over 30,000 employees with critical institutional knowledge.

Bristol-Myers Squibb Partners With Anthropic To Deploy AI

The partnership with Anthropic marks a significant step for Bristol-Myers Squibb in integrating AI into its workflows, focusing on areas expected to yield high impact.

Read Also:

Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma

The initiative builds on over three years of AI investment ...